IZI Medical Launches Osteo-Site Vertebral Balloon
The company launched the Osteo-Site Vertebral Balloon for vertebral augmentation, completing IZI's line of Vertebral Compression Fracture treatment options. Aug 25, 2020
DiscGenics Raises $50 Million in Series C Funding
The company will use the capital to support ongoing clinical trials of its injectable Discogenic Cell Therapy (IDCT) for lumbar degenerative disc disease. Aug 25, 2020
Bodycad Completes First Case of BC Fine Osteotomy
The company completed its first case in Canada of the lateral open wedge distal femoral osteotomy for the treatment of knee malalignment. Aug 25, 2020
Ortho Regenerative Technologies Closes $2.5 Million Private Placement
The company raises the funds through a non-brokered private placement. The proceeds will fund initiatives like securing FDA approval for clinical trials. Aug 24, 2020
Xtant Medical Launches Matriform Si for Spinal Fusion
The company announced the U.S. commercial launch of the Matriform Si, a silicated synthetic bone graft substitute designed and cleared for spinal fusion. Aug 24, 2020
Episurf Medical Reached Milestone 800th Implant of Episealer
The Sweden-based company reached another milestone for the Episealer knee implant, as it plans the 800th surgery for the product. Aug 24, 2020
AK Medical Expands 3D Printer Fleet to Meet Growing Demand
The company expanded its 3D printing capacity by investing in eight GE Arcam EMB 3D printers to address the orthopedic needs of China's aging population. Aug 24, 2020
Medartis Keeps Pace with Priorities Amid COVID
Despite the impact of COVID, the company forged ahead with its priorities, including expanding its U.S. business and accelerating its innovation pipeline. Aug 19, 2020
Orthopedic Market Recovery Rate Accelerates in 2Q20
The orthopedic market recovery rate accelerated in 2Q and delivered better results than expected, but questions about the new patient pipeline remain. Aug 17, 2020
Integra Claws Back from Massive April Declines
The company's orthopedic sales declined -49% in 2Q20 but recovered significantly from -80% declines in April. Integra expects improvement through 2H20. Aug 13, 2020
